Stocks · Health care · Biological Products, (No Diagnostic Substances)

Biogen

BIIB Clue Score50

United States Fiscal year ends December CIK 0000875045 Results filed 28 Oct 2026

Add to watchlist

What the insiders did Mostly scheduled

By person

21 insiders · 5 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Priya Singhal

Head of Development

—

$665.66K (2) scheduled

−$665.66K

8,043

0.0054%

$1.62M

+46.7%

Lloyd Minor

Director

—

$239.75K (2) scheduled

−$239.75K

2,689

0.0018%

$540.38K

—

Nicole Murphy

Head of Pharm Ops and Tech

$585.11 (1)

—

+$585.11

19,611

0.0133%

$3.94M

+100.1%

Susan H Alexander

EVP Chief Legal Officer

—

—

—

41,807

0.0283%

$8.40M

+32.3%

Caroline Dorsa

Director

—

—

—

31,002

0.0210%

$6.23M

+16.5%

Christopher Viehbacher

President and CEO

—

—

—

29,924

0.0203%

$6.01M

+327.5%

Eric K Rowinsky

Director

—

—

—

25,844

0.0175%

$5.19M

+17.6%

Michael R. McDonnell

EVP, Chief Financial Officer

—

—

—

24,341

0.0165%

$4.89M

+25.4%

Ginger Gregory

EVP, Human Resources

—

—

—

22,359

0.0151%

$4.49M

+61.5%

Stephen A Sherwin

Director

—

—

—

15,193

0.0103%

$3.05M

−24.3%

Robin Kramer

Chief Financial Officer

—

—

—

11,472

0.0078%

$2.31M

+84.2%

Jesus B Mantas

Director

—

—

—

11,263

0.0076%

$2.26M

+52.4%

Rachid Izzar

Head of Global Product Strat.

—

—

—

11,011

0.0075%

$2.21M

+137.6%

William A Hawkins

Director

—

—

—

10,365

0.0070%

$2.08M

+59.7%

Maria C Freire

Director

—

—

—

8,820

0.0060%

$1.77M

+98.4%

Susan Langer

Director

—

—

—

6,634

0.0045%

$1.33M

+140.4%

Adam Keeney

Head of Corporate Development

—

—

—

6,365

0.0043%

$1.28M

+861.5%

Monish D Patolawala

Director

—

—

—

5,215

0.0035%

$1.05M

+289.2%

Jane Grogan

Head of Research

—

—

—

4,408

0.0030%

$885.83K

+797.8%

Menelas N Pangalos

Director

—

—

—

3,875

0.0026%

$778.72K

—

Sean Godbout

Chief Accounting Officer

—

—

—

1,459

0.0010%

$293.20K

+153.7%